Boothbay Fund Management, LLC Verve Therapeutics, Inc. Transaction History
Boothbay Fund Management, LLC
- $3.28 Billion
- Q1 2025
A detailed history of Boothbay Fund Management, LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 105,595 shares of VERV stock, worth $1.18 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
105,595
Previous 53,317
98.05%
Holding current value
$1.18 Million
Previous $300,000
60.67%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding VERV
# of Institutions
201Shares Held
79.5MCall Options Held
204KPut Options Held
101K-
Alphabet Inc. Mountain View, CA12.3MShares$138 Million5.03% of portfolio
-
Bvf Inc San Francisco, CA6.9MShares$77 Million1.39% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$73.9 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$44.6 Million2.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$44.1 Million0.0% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $669M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...